Croda International (LON:CRDA – Get Free Report) had its price objective reduced by Jefferies Financial Group from GBX 3,200 to GBX 3,100 in a report released on Friday, Marketbeat.com reports. The firm currently has a “buy” rating on the stock. Jefferies Financial Group’s price target points to a potential upside of 7.86% from the company’s current price.
Several other brokerages also recently commented on CRDA. Berenberg Bank reduced their target price on Croda International from GBX 3,800 to GBX 3,100 and set a “buy” rating for the company in a research note on Tuesday, July 29th. Deutsche Bank Aktiengesellschaft reduced their price objective on Croda International from GBX 3,400 to GBX 3,000 and set a “hold” rating for the company in a research note on Tuesday, July 29th. Citigroup decreased their price objective on Croda International from GBX 3,300 to GBX 3,050 and set a “neutral” rating for the company in a report on Friday, October 3rd. Finally, JPMorgan Chase & Co. raised shares of Croda International to an “overweight” rating in a research report on Wednesday, July 30th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Croda International currently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 3,137.50.
Check Out Our Latest Analysis on Croda International
Croda International Stock Performance
Croda International (LON:CRDA – Get Free Report) last issued its earnings results on Tuesday, July 29th. The company reported GBX 72.20 earnings per share (EPS) for the quarter. Croda International had a net margin of 9.98% and a return on equity of 6.96%. As a group, sell-side analysts anticipate that Croda International will post 181.8307268 EPS for the current year.
Insider Transactions at Croda International
In other news, insider Jacqui Ferguson acquired 393 shares of Croda International stock in a transaction on Friday, August 22nd. The stock was acquired at an average cost of GBX 2,524 per share, with a total value of £9,919.32. Also, insider Steve Foots acquired 3,815 shares of the firm’s stock in a transaction on Monday, August 4th. The stock was purchased at an average price of GBX 2,617 per share, with a total value of £99,838.55. Over the last 90 days, insiders have purchased 11,333 shares of company stock worth $29,793,789. 0.83% of the stock is owned by insiders.
Croda International Company Profile
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.
Featured Stories
- Five stocks we like better than Croda International
- Profitably Trade Stocks at 52-Week Highs
- Johnson & Johnson’s M&A Strategy Is the Real Story for Investors
- How to Read Stock Charts for Beginners
- Tesla: Some Analysts Are Calling for A 30% Drop—Time to Panic?
- How Technical Indicators Can Help You Find Oversold Stocks
- Hedge Funds Flip on the Dollar—A Buy Signal for These 3 Stocks?
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.